Skip to main content

Table 2 Study schedule at each visit in the clinical trial

From: Effects of a novel nutraceutical combination (BruMeChol™) in subjects with mild hypercholesterolemia: study protocol of a randomized, double-blind, controlled trial

 

Study schedule

 

Screening

Baseline (visit 1)

6th week (visit 2)

12th week (visit 3)

Informed consent form

X

   

Recording demographic data

X

   

Medical history taking

 

X

 

X

Physical examination a

X

X

X

X

Glycemia

X

X

X

X

Renal functionb

X

X

X

X

Liver functionc

X

X

X

X

Thyrotropin-TSH

X

   

Lipid profiled

X

X

X

X

Fool blood exam-FBEe

 

X

X

X

Leukocytes formulaf

 

X

X

X

Electrolytesg

 

X

X

X

Cardiac/muscular markersh

 

X

X

X

C-reactive protein

 

X

X

X

Lipoprotein (a)

 

X

X

X

Interleukinsi

 

X

X

X

Inflammatory-miRsj

 

X

X

X

ECGk

 

X

 

X

  1. aWeight, height, waist circumference, and hip circumference
  2. bCreatinine; estimated glomerular filtration rate by CKD-EPI equation
  3. cAspartate aminotransferase glutamic oxaloacetic transaminase (AST/GOT), alanine aminotransferase/ glutamic pyruvic transaminase (ALT/GPT)
  4. dTotal cholesterol, triglyceride, low-density cholesterol (LDL), and high-density cholesterol (HDL)
  5. eWhite blood cells (WBCs), red blood cells (RBCs), hemoglobin, hematocrit, mean cell volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red cell distribution width (RDW), platelets
  6. fNeutrophils, eosinophils, basophils, lymphocytes, monocytes
  7. gSodium, potassium, chlorine, calcium, phosphorus, magnesium
  8. hCardiac Markers Creatine Kinase (CK)/ myoglobin
  9. iIL6, IL32, IL37, IL38
  10. jmiR-21 and miR-146a
  11. kElectrocardiography
Back to article page

Trials

ISSN: 1745-6215